Skip to main content
Prime Rate:6.75%Fed Funds:3.64%5-Yr Treasury:3.88%10-Yr Treasury:4.25%30-Yr Treasury:4.83%30-Yr Mortgage:6.22%·Updated Mar 19, 2026Prime Rate:6.75%Fed Funds:3.64%5-Yr Treasury:3.88%10-Yr Treasury:4.25%30-Yr Treasury:4.83%30-Yr Mortgage:6.22%·Updated Mar 19, 2026
Rates
Snyder Drug

Snyder Drug

Franchising since 1928 · 2 locations

Snyder Drug currently operates 2 locations (2 franchised). The top SBA 7(a) lenders for Snyder Drug are Twin Cities-Metro Certified De and First Bank & Trust. PeerSense FPI health score: 38/100.

Total Units

2

2 franchised

FPI Score
Low
38

Proprietary PeerSense metric

Fair
Capital Partners
2lenders available

Active capital sources verified for Snyder Drug financing

SBA

7(a) Eligible

21d

Avg Funding

P+2.25%

Best Rate

No retainers · Referral fee at closing

FPI Score Breakdown

New/Niche (1-2 loans)

Limited Data
38out of 100
Fair

SBA Lending Performance

SBA Default Rate

0.0%

0 of 2 loans charged off

SBA Loans

2

Total Volume

$0.6M

Active Lenders

2

States

1

Top SBA Lenders for Snyder Drug

What is the Snyder Drug franchise?

The Snyder Drug franchise, as an emerging entity within the competitive landscape of pharmacies and drug stores, represents a distinct operational model focused on community-centric health and wellness services. With a current footprint of 2 total units, the Snyder Drug franchise is in an early phase of its growth trajectory, yet it positions itself within a sector that has historically demonstrated resilience and consistent demand across diverse economic cycles. The foundation of any successful pharmacy chain often rests upon a commitment to patient care, accessible healthcare solutions, and the integration of essential retail offerings, principles that are inherently critical for the long-term viability and expansion of this brand. The market for pharmacies and drug stores has evolved significantly over recent decades, transitioning from purely transactional retail spaces to comprehensive health hubs. This shift includes the provision of prescription services, over-the-counter medications, personal care products, and increasingly, preventative health screenings and immunizations. The strategic market position for a brand like Snyder Drug would typically involve identifying underserved communities or refining service delivery in existing markets to create a differentiated patient experience. The modest initial scale of 2 units suggests a foundational period, potentially focused on perfecting the operational playbook and refining the value proposition before embarking on a broader expansion initiative. This controlled growth allows for meticulous attention to detail in service delivery and localized market adaptation, ensuring that each Snyder Drug location establishes a strong community presence and builds a loyal customer base. The category of pharmacies and drug stores is characterized by high regulatory oversight and a constant need for adaptation to evolving healthcare policies and consumer expectations, factors that the Snyder Drug franchise must navigate effectively to secure its future market standing. The strategic vision for Snyder Drug would likely encompass

FPI Score

38/100

SBA Default Rate

0.0%

Active Lenders

2

Key Highlights

Low SBA default rate (0.0%)

Data Insights

Key performance metrics for Snyder Drug based on SBA lending data

SBA Default Rate

0.0%

0 of 2 loans charged off

SBA Loan Volume

2 loans

Across 2 lenders

Lender Diversity

2 lenders

Avg 1.0 loans per lender

Snyder Drug — Deep SBA Data

Brand-specific metrics derived directly from SBA 7(a) approval records — peak lending year, leading state, average loan size, and lender concentration. PeerSense computes these per brand so capital advisors and prospective franchisees can benchmark this opportunity against the rest of the franchise universe.

Peak SBA Year

1995

1 approvals — best year on record for Snyder Drug.

Top SBA State

Minnesota

2 SBA-financed Snyder Drug locations — the densest operator footprint.

Average Loan Size

$280K

Median $280K — use as a sizing anchor when modeling your own $Snyder Drug unit.

Lender Concentration

100%

Concentrated

Share of Snyder Drug approvals captured by the top 3 SBA lenders.

Snyder Drug's SBA lending pipeline peaked in 1995 (1 approvals). Operator density is highest in Minnesota with 2 SBA-financed locations. Average funded ticket sits at $280K, with the median at $280K. Lender mix is concentrated: the top three SBA lenders account for 100% of approvals — credit decisions concentrate with a small group of incumbents.

Payment Estimator

Loan Amount$400K
Interest Rate9.5%
Term (Years)10 yr

Estimated Monthly Payment

$5,176

Principal & Interest only

Locations

Snyder Drugunit breakdown

Total Units
N/A
Franchisee Owned
System Owned
Closed

Explore Funding for Snyder Drug

Our business financing consultants help connect you with the right lending partners. No retainers — referral fee paid at closing.

One more step: check the consent box above and type your full legal name as signature to enable submission.

No retainers · Referral fee at closing

Or get an instant analysis

Scan Your Deal Instantly
Snyder Drug